Cell targeting peptide guided nanomedicine: a new paradigm in precision oncology for the management of non-small cell lung cancer.
Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide owing to its high prevalence, metastatic potential, therapeutic resistance and poor survival outcomes. Effective management of NSCLC is hindered by the heterogeneous tumor microenvironment (TME), non-selective drug biodistr...